Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions
about
Heparan sulfate and heparin interactions with proteinsGlycosaminoglycan glycomics using mass spectrometryMutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivoFell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.GlycReSoft: a software package for automated recognition of glycans from LC/MS dataOligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.Tandem mass spectrometry of heparan sulfate negative ions: sulfate loss patterns and chemical modification methods for improvement of product ion profilesA liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.Investigating the mechanism of the assembly of FGF1-binding heparan sulfate motifsDrosophila heparan sulfate, a novel design.Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology.Heparan Sulfate Domains Required for Fibroblast Growth Factor 1 and 2 Signaling through Fibroblast Growth Factor Receptor 1c.Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printingNew targets for glycosaminoglycans and glycosaminoglycans as novel targets.Heparan sulfate-protein binding specificity.Heparan sulfate in angiogenesis: a target for therapy.Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles.'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.A computational framework for heparan sulfate sequencing using high-resolution tandem mass spectra.Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.
P2860
Q26796383-41324AE2-1B00-4E0F-ABA5-9E15EA34227BQ26823079-BE1DCBC7-78BD-4623-ABFD-5536095F497BQ30407670-0A6FC1D3-6E37-471B-8525-CD8E716F45BEQ30568524-E3365B12-6620-40A1-9A0E-4E1117B6572CQ30572721-BA635AA4-4628-4490-B99B-9A9811973F24Q34050837-6069FF17-21E2-43D1-B2CC-9E9BEC8A8C7FQ34097643-516588CA-621F-4D82-A2F9-B674C0508D00Q34634250-BE5D214F-584D-4E8D-B7BC-E467958BEF23Q35186439-B73C5B2D-E8C7-44C5-80B1-016FF557F622Q36052448-D81050ED-2D95-4FBB-B1E8-5C3752A26650Q36169514-E4FED70A-1E7B-4E9E-97BD-CAC5C4878765Q36235128-1D3714B6-0FED-4095-BEE4-A491E8D6FC61Q37683396-787F8015-A881-42FA-8225-F35912E201AFQ38081956-53A1F709-9E40-403E-B02F-8797CB08CDEEQ38134808-B7E63B10-9F7B-4231-9B02-1CC6458B1FDBQ38154506-26106C11-9140-4D32-941B-93B712BB9FD2Q38175867-32B200C5-FC1E-44C4-B1BC-8AC8F0161E01Q38989457-FB0B4D7A-F139-49CB-AE18-741BE698C40FQ38995855-4589B435-4426-4EC2-8C8D-234C1DDF0341Q41998384-F40619FE-A2D4-4026-9E95-2B60C889976AQ47148090-78DCE418-86CD-4DC5-9862-6BF520412F50
P2860
Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Highly sulfated nonreducing en ...... biologically active fractions
@ast
Highly sulfated nonreducing en ...... biologically active fractions
@en
type
label
Highly sulfated nonreducing en ...... biologically active fractions
@ast
Highly sulfated nonreducing en ...... biologically active fractions
@en
prefLabel
Highly sulfated nonreducing en ...... biologically active fractions
@ast
Highly sulfated nonreducing en ...... biologically active fractions
@en
P2093
P2860
P356
P1476
Highly sulfated nonreducing en ...... biologically active fractions
@en
P2093
Hicham Naimy
Jo Ann Buczek-Thomas
Matthew A Nugent
Nancy Leymarie
P2860
P304
19311-19319
P356
10.1074/JBC.M110.204693
P407
P50
P577
2011-04-06T00:00:00Z